WFIRM's goal is to apply the principles of regenerative medicine to repair or replace diseased tissues and organs. Among other goals, WFIRM scientists are looking for ways to create insulin-producing cells in the laboratory, engineered blood vessels for heart bypass surgery and treat knee injuries through regenerated meniscus tissues.[1] WFIRM has also led two federal initiatives to regenerate tissues from battlefield injuries (AFIRM I and AFIRM II), with a combined funding of $160 million from the U.S. Department of Defense.[2] WFIRM is working to develop more than 40 different organs and tissues in the laboratory.
In 2019, the U.S. federal Department of Health and Human Services (HHS) provided a 5-year grant through BARDA to support further development of WFIRM technology to better understand damage to the body caused by inhaling chlorine gas. The technology is called "lung-on-a-chip" and is a part of a "miniaturized system of human organs" developed by WFIRM that can allow researchers to create models of the body's response to harmful agents.[8]
The Institute also is involved in research on energy fields and the human biofield. This led to a retracted article on Energy Medicine. [9]